Armistice Capital, LLC Pro Mis Neurosciences Inc. Transaction History
Armistice Capital, LLC
- $6.02 Billion
- Q3 2024
A detailed history of Armistice Capital, LLC transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 2,670,000 shares of PMN stock, worth $2.4 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,670,000Holding current value
$2.4 Million% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding PMN
# of Institutions
20Shares Held
10.1MCall Options Held
0Put Options Held
0-
Great Point Partners LLC Greenwich, CT2.79MShares$2.51 Million1.61% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.93MShares$1.74 Million0.44% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY1.59MShares$1.43 Million1.41% of portfolio
-
Altium Capital Management LP New York, NY581KShares$523,2550.26% of portfolio
-
Heights Capital Management, Inc San Francisco, CA387KShares$348,2040.36% of portfolio
About ProMIS Neurosciences Inc.
- Ticker PMN
- Exchange OTC
- Description
- ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...